Functional and structural characterization of a combination of pan-sarbecovirus antibodies with potent antiviral activity
Marden, G. C.; Schmitt, K. P.; Zimmerman, M. I.; Ramos, A. H.; Menzenski, M. Z.; Sharma, G.; Li, H.; Carlin, E.; Jecrois, A.; Morales-Perez, C. L.; Palovcak, E.; Garlick, J. D.; Hannigan, B.; Russell, P.; Federman, R. S.; Leung, A.; Vargas, N. L.; Shaban, N. M.; Vaidya, V.; Towler, H.; Joh, N. H.; Lord, D. M.; Tao, J.; Costello, Z.; Frappier, V.; Hopson, K.; Pegu, A.; Koh, G. C. K. W.; Van Epps, H.; Root, A.; Grigoryan, G.; Hazuda, D.; Borriello, F.
Show abstract
Sarbecoviruses, a subgenus of coronaviruses, include strains with zoonotic spillover risk as exemplified by recent outbreaks (SARS-CoV-1, SARS-CoV-2). Monoclonal antibodies targeting conserved spike protein regions (RBD class 4, S2 fusion machinery) exhibit broad sarbecovirus neutralization, but their utility has been impacted by immune selection leading to escape and suboptimal neutralization. Using structure-conditioned machine-learning protein design we optimized two broadly neutralizing sarbecovirus antibodies to rescue the activity of a class 4 anti-RBD antibody against Omicron variants and improve the neutralization profile of an anti-S2 stem antibody, resulting in the identification of the lead candidates PRO-37587 and GB-0669. Both antibodies displayed remarkable resilience to SARS-CoV-2 evolution. Structural analyses elucidated the mechanistic basis of their broad neutralization profiles. In combination, these antibodies exhibited improved SARS-CoV-2 neutralization in vitro and in vivo and a higher barrier to resistance. These findings support further evaluation of such antibody combination as countermeasure against current and emerging sarbecoviruses.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates 97%
- Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 97%
- Distinct pathway for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses 96%
Similar papers in this journal
- Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination 98%
- Mapping essential somatic hypermutations in a CD4-binding site bNAb informs HIV-1 vaccine design 97%
- Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses 97%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.